ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

PHVS Pharvaris NV

22.60
0.00 (0.00%)
プレマーケット
最終更新日: 17:09:39
15分遅延
名称 銘柄コード 市場 種別
Pharvaris NV PHVS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 22.60 17:09:39
始値 安値 高値 終値 前日終値
22.60
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1105:10GLOBEPharvaris Reports Fourth Quarter and Full Year 2023..
2024/4/1105:08GLOBEPharvaris Appoints David Nassif, J.D., as Chief Financial..
2024/4/0419:50GLOBEPharvaris to Present Deucrictibant Clinical Data at the CIIC..
2024/3/1819:50GLOBEPharvaris Announces Phase 3 Clinical Study Design for..
2024/3/1202:51EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0706:40EDGAR2Form F-3ASR - Automatic shelf registration statement of..
2024/3/0706:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0620:50GLOBEPharvaris to Present Deucrictibant Clinical Data at Upcoming..
2024/3/0520:50GLOBEPharvaris to Participate in the Leerink Global Biopharma..
2024/2/2220:50GLOBEPositive Results from CHAPTER-1 Phase 2 Study of..
2024/2/1620:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1620:50GLOBEPharvaris Announces Extraordinary Meeting of Shareholders
2024/2/0806:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0206:46EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2620:50GLOBEPharvaris to Present at the WSAAI Annual Meeting 2024
2024/1/2221:35DJNPharvaris Says FDA Lifted Clinical Hold on Application for..
2024/1/2220:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2220:50GLOBEPharvaris Announces FDA Lifting of the Clinical Hold of..
2024/1/0821:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0520:50GLOBEPharvaris Provides Business Update and Outlines 2024..
2024/1/0306:29EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0908:00GLOBEPharvaris Presents Deucrictibant Clinical Data and Analysis..
2023/12/0906:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0806:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0706:36EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0621:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2023/12/0621:02GLOBEPharvaris Announces Pricing of $300 Million Underwritten..
2023/12/0620:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/0620:50GLOBEPharvaris Announces Positive Top-line Phase 2 Data from the..
2023/11/3020:50GLOBEPharvaris to Present at the GA²LEN UCARE Conference 2023
2023/11/1520:50GLOBEPharvaris Appoints Stefan Abele, Ph.D., as Chief Technical..
2023/11/1001:00GLOBEPharvaris Presents Deucrictibant Clinical Data and..
2023/11/0219:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0219:50GLOBEPharvaris Reports Third Quarter 2023 Financial Results and..
2023/10/3019:50GLOBEPharvaris To Present at the ACAAI 2023 Annual Scientific..
2023/10/1319:50GLOBEPharvaris To Present at the APAAACI 2023 International..
2023/10/0420:34GLOBEPharvaris To Present at the CIIC Fall 2023 Conference
2023/9/2005:23EDGAR2Form 144 - Report of proposed sale of securities
2023/9/1919:50GLOBEPharvaris To Participate in the 2023 Cantor Global..
2023/9/0619:51GLOBEPharvaris To Present at the 18th German Allergy Congress
2023/9/0619:50GLOBEPharvaris To Participate in the Morgan Stanley 21st Annual..
2023/9/0207:02EDGAR2Form 144 - Report of proposed sale of securities
2023/8/2505:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/2319:50GLOBEPharvaris To Present at the 2023 HAEi Regional Conference..
2023/8/1713:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/1008:00EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1007:38EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0723:16EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/8/0719:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0719:50GLOBEPharvaris Reports Second Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock